The Gross Margin of Shanghai Henlius Biotech Inc (2696.HK) is 73.10%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 73.10% |
| 2023-12-31 | 72.64% |
| 2022-12-31 | 73.73% |
| 2021-12-31 | 68.93% |
| 2020-12-31 | 69.01% |
| 2019-12-31 | 21.01% |
| 2018-12-31 | 27.26% |
| 2017-12-31 | 55.71% |